AU2003276982A8 - Phenylalkylamines and pyridylalkylamines with serotoninergic receptor affinity - Google Patents

Phenylalkylamines and pyridylalkylamines with serotoninergic receptor affinity

Info

Publication number
AU2003276982A8
AU2003276982A8 AU2003276982A AU2003276982A AU2003276982A8 AU 2003276982 A8 AU2003276982 A8 AU 2003276982A8 AU 2003276982 A AU2003276982 A AU 2003276982A AU 2003276982 A AU2003276982 A AU 2003276982A AU 2003276982 A8 AU2003276982 A8 AU 2003276982A8
Authority
AU
Australia
Prior art keywords
pyridylalkylamines
phenylalkylamines
receptor affinity
serotoninergic receptor
serotoninergic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003276982A
Other versions
AU2003276982A1 (en
Inventor
Carlo Riva
Amedeo Leonardi
Gianni Motta
Luciano Guarneri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Recordati SA
Original Assignee
Recordati SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Recordati SA filed Critical Recordati SA
Publication of AU2003276982A1 publication Critical patent/AU2003276982A1/en
Publication of AU2003276982A8 publication Critical patent/AU2003276982A8/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20—Oxygen atoms
    • C07D215/22—Oxygen atoms attached in position 2 or 4
    • C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/10—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms
    • C07D211/14—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with radicals containing only carbon and hydrogen atoms attached to ring carbon atoms with hydrocarbon or substituted hydrocarbon radicals attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/40—Oxygen atoms
    • C07D211/44—Oxygen atoms attached in position 4
    • C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU2003276982A 2002-06-14 2003-06-16 Phenylalkylamines and pyridylalkylamines with serotoninergic receptor affinity Abandoned AU2003276982A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ITMI2002A001329 2002-06-14
IT2002MI001329A ITMI20021329A1 (en) 2002-06-14 2002-06-14 NEW OXIALYKYLAMES REPLACED
PCT/EP2003/006290 WO2003106421A2 (en) 2002-06-14 2003-06-16 Phenylalkylamines and pyridylalkylamines

Publications (2)

Publication Number Publication Date
AU2003276982A1 AU2003276982A1 (en) 2003-12-31
AU2003276982A8 true AU2003276982A8 (en) 2003-12-31

Family

ID=29727278

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003276982A Abandoned AU2003276982A1 (en) 2002-06-14 2003-06-16 Phenylalkylamines and pyridylalkylamines with serotoninergic receptor affinity

Country Status (4)

Country Link
AU (1) AU2003276982A1 (en)
IT (1) ITMI20021329A1 (en)
TW (1) TW200409632A (en)
WO (1) WO2003106421A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0957073A1 (en) 1998-05-12 1999-11-17 Schwarz Pharma Ag Novel derivatives of 3,3-diphenylpropylamines
DE10315917A1 (en) * 2003-04-08 2004-11-18 Schwarz Pharma Ag Highly pure bases of 3,3-diphenylpropylamine monoesters
WO2012030894A1 (en) 2010-09-01 2012-03-08 Ambit Biosciences Corporation Thienopyridine and thienopyrimidine compounds and methods of use thereof
WO2012030944A2 (en) 2010-09-01 2012-03-08 Ambit Biosciences Corporation Quinoline and isoquinoline compounds and methods of use thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE671440A (en) *
WO1994003444A1 (en) * 1992-08-05 1994-02-17 John Wyeth & Brother Limited Amide derivatives
GB9304632D0 (en) * 1993-03-06 1993-04-21 Wyeth John & Brother Ltd Amide derivatives
GB9408872D0 (en) * 1994-05-03 1994-06-22 Zeneca Ltd Heterocyclic compounds
US5525600A (en) * 1994-11-28 1996-06-11 American Home Products Corporation (Thiophen-2-yl)-piperidin or tetrahydropyridin carboxamides
US5610164A (en) * 1996-07-24 1997-03-11 American Home Products Corporation (Thiophen-2-yl)-piperidin or tetrahydropyridin azabicyclocarboxamides
UA66370C2 (en) * 1997-12-16 2004-05-17 Lilly Co Eli Arylpiperazines having activity to setotonin 1 receptors
CA2336117A1 (en) * 1998-06-30 2000-01-06 Sidney Xi Liang Piperidine derivatives having effects on serotonin related systems

Also Published As

Publication number Publication date
TW200409632A (en) 2004-06-16
ITMI20021329A1 (en) 2003-12-15
AU2003276982A1 (en) 2003-12-31
WO2003106421A2 (en) 2003-12-24
WO2003106421A3 (en) 2004-06-17

Similar Documents

Publication Publication Date Title
HK1248731A1 (en) Immunoglobulin variants and uses thereof
EP1746902A4 (en) Multi-lectin affinity chromatography and uses thereof
IL158808A0 (en) 5-ht receptor ligands and uses thereof
HK1089438A1 (en) Quinoline and quinazoline derivatives having affinity for 5ht1-type receptors
EP1539941A4 (en) Adzymes and uses thereof
AU2002347022A1 (en) Benzimidazols and indols as glucagon receptor antagonists/inverse agonisten
AU2003220205A8 (en) Ethanol-diesel fuel composition and methods thereof
EG24035A (en) Gantry with auto-adjusting prestressing
PL377770A1 (en) Substituted benzoxazinones and uses thereof
AU2003228205A8 (en) Porous polymers: compositions and uses thereof
AU2003298129A8 (en) Floor-furnace chimney and the use thereof
TWI318229B (en) Dyes having adapted affinity
EP1534332A4 (en) Antibodies and uses thereof
AU2003276982A8 (en) Phenylalkylamines and pyridylalkylamines with serotoninergic receptor affinity
PL370221A1 (en) 2-oxazolamines and their use as 5-ht2b receptor antagonists
AU2003231827A8 (en) Pseudo-tissues and uses thereof
AU2003276048A8 (en) Heteroaryl propyl-piperazines and heteroaryl propyl-piperidines serving as dopaminergic and serotoninergic agents
GB0221579D0 (en) Combinations of atorvastatin and, adrenergic receptor antagonists
GB0124346D0 (en) Receptor and its use
TW514163U (en) Pivoting device with adjustable limiting point resistance
GB0216200D0 (en) Polypeptides and uses thereof
GB0211205D0 (en) Receptor and ligand
GB0211204D0 (en) Receptor and its ligand
GB0203305D0 (en) Aptitude testing
GB0218253D0 (en) Novel composition and use

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase